Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Academia Sinica: Characterization and identification of pulmonary stem cells as a target for viral infection

BiotechEast Co., Ltd. (Technology Partner)
The technology involves the characterization and identification of pulmonary stem cells as a target for viral infection. Application includes respiratory infection cell model, respiratory infection drug screening, lung tissue regenerative therapy

Full description

A serum-free culture system that can support the growth of lung stem/progenitor cells has been developed. The neonatal lung-derived epithelial colony cells which express the stem cell markers such as Oct-4, SSEA-1, Sca-1 were identified. These Oct-4 colony cells represent a subpopulation of Clara cells, which have been long implicated in lung repair and regeneration after injury. Moreover, these cells are capable of differentiation into type-2 and -1 pneumocytes and are susceptible to respiratory virus infection (e.g. SARS, influenza, Avian flu).

It is expected that these cells may be used in the establishment of flu drug evaluation and/or screening platforms, used in the place of the existing kidney cell infection model. Also, the capability of these cells in viral collection could be advantageous for the research and development of vaccines. Long term, lung tissue regenerative therapy could be developed resulting from the use of this system.

 

Development status

Early Stage

Patent information

US 11/252458
EU, TW, JP, Australian patents are pending

Type of business relationship sought

Licensing or research cooperation

Partnering consultation free of charge
EuroPLX 38 + 39
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us